Biomerica Inc
BMRA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000073290
In the last 90 days, Biomerica Inc insiders filed 5 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $220.0K in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Biomerica Inc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −2 vs. Q1 2022
- Shares held
- 2.43M
- −93.8K (−3.7%) vs. Q1 2022
- Total value
- $7.01M
- −$4.25M (−37.8%) vs. Q1 2022
- New holders
- 0
- 7 more added
- Sold out
- 2
- 8 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $220.0K |
| Q1 2026 | 11 | $236.1K |
| Q4 2025 | 13 | $225.4K |
| Q3 2025 | 17 | $251.3K |
| Q2 2025 | 12 | $219.6K |
| Q1 2025 | 24 | $542.9K |
| Q4 2024 | 21 | $420.8K |
| Q3 2024 | 25 | $532.7K |
| Q2 2024 | 35 | $982.4K |
| Q1 2024 | 36 | $3.10M |
| Q4 2023 | 33 | $4.68M |
| Q3 2023 | 35 | $3.43M |
| Q2 2023 | 36 | $6.00M |
| Q1 2023 | 34 | $8.83M |
| Q4 2022 | 30 | $11.6M |
| Q3 2022 | 31 | $11.6M |
| Q2 2022 | 26 | $7.01M |
| Q1 2022 | 28 | $11.3M |
| Q4 2021 | 24 | $9.29M |
| Q3 2021 | 22 | $11.0M |
| Q2 2021 | 27 | $10.2M |
| Q1 2021 | 32 | $20.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Biomerica Inc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Ahrens Investment Partners LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,630 | $5.00K | 0.00% | −887−35.2% | Reduced |
| Tower Research Capital LLC (TRC) | 2,764 | $8.00K | 0.00% | +1,456+111.3% | Added |
| Bank of America Corp | 4,032 | $12.0K | 0.00% | −968−19.4% | Reduced |
| Wells Fargo & Company | 6,571 | $19.0K | 0.00% | +5+0.1% | Added |
| Simplex Trading, LLC | 8,605 | $24.0K | 0.00% | −486−5.3% | Reduced |
| HCR Wealth Advisors | 10,000 | $29.0K | 0.01% | 00.0% | Unchanged |
| Orion Capital Management LLC | 11,500 | $33.0K | 0.03% | 00.0% | Unchanged |
| Group One Trading, L.P. | 11,932 | $34.0K | 0.00% | −15,500−56.5% | Reduced |
| Citadel Advisors LLC | 13,457 | $39.0K | 0.00% | −19,353−59.0% | Reduced |
| Northern Trust Corp | 16,746 | $48.0K | 0.00% | −1,645−8.9% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 18,148 | $52.0K | 0.00% | +4,486+32.8% | Added |
| Emerald Advisers, LLC | 19,000 | $55.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 26,072 | $75.0K | 0.00% | −391−1.5% | Reduced |
| Susquehanna International Group, LLP | 29,902 | $86.0K | 0.00% | +19,402+184.8% | Added |
| Perritt Capital Management Inc | 30,000 | $87.0K | 0.05% | 00.0% | Unchanged |
| GWM Advisors LLC | 32,900 | $95.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 55,831 | $161.0K | 0.00% | 00.0% | Unchanged |
| Ridgewood Investments LLC | 60,000 | $173.0K | 0.14% | 00.0% | Unchanged |
| Heritage Investors Management Corp | 70,350 | $203.0K | 0.01% | +1,000+1.4% | Added |
| Geode Capital Management, LLC | 78,006 | $225.0K | 0.00% | +757+1.0% | Added |
| Fore Capital, LLC | 85,000 | $246.0K | 0.63% | 00.0% | Unchanged |
| BlackRock Inc. | 184,341 | $533.0K | 0.00% | +416+0.2% | Added |
| Vanguard Group Inc | 545,951 | $1.58M | 0.00% | 00.0% | Unchanged |
| Granahan Investment Management Inc | 1,102,993 | $3.19M | 0.11% | −66,848−5.7% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,812−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,415−100.0% | Sold out |